THE SOVEREIGN MANDATE: 5 Stocks Securing the 2026 Choke Points

Article content

Issued on behalf of QSE – Quantum Secure Encryption Corp.

Article content

VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) — USANewsGroup.com Market Intelligence Brief –

Article content

Article content

The era of abundance has reached its limit.

Article content

The speculative fever of the last decade has been replaced by a scramble for the “Choke Point.” The physical and digital bottlenecks that control the 2026 economy.

Article content

Investors are no longer buying “potential.” They are buying the load-bearing walls of the real economy: The encryption that protects the state, the data that drives the drug, and the metals that build the grid.

Article content

Article content

If you do not own the bottleneck, you do not own the future.

Article content

Article content

The companies below control the gates. They are the beneficiaries of a structural flight to the essentials. Sovereignty, security, and survival.

Article content

THE DIGITAL SOVEREIGNTY

Article content

QSE – Quantum Secure Encryption Corp. (CSE: QSE) (OTCQB: QSEGF) is scaling its operational capacity to meet a massive regulatory earthquake, having recently confirmed a significant expansion of its global footprint to five countries across three regions.

Article content

The timing is precise. Today, January 14, the “Year of Quantum Security” officially launches in Washington, D.C., a global coordination effort backed by the FBI and NIST to secure critical data against future decryption.

Article content

The mandate is clear. Over 70% of the world’s GDP will soon be generated in countries with strict data sovereignty laws. Governments and financial institutions are being forced to modernize their digital shields or face exclusion from the global economy.

Article content

QSE is capturing this $30 billion tech migration at the source.
By partnering with NUSA Networks in Indonesia, the company has secured a force-multiplier for its technology, fast-tracking its quantum-resilient algorithms into critical national infrastructure.

Article content

Article content

This is the ultimate Choke Point. You cannot have a sovereign digital economy if your data can be harvested and decrypted by foreign adversaries. QSE is providing the lock for the new digital border.

Article content

Article content

THE CLINICAL SIGNAL

Article content

Oncolytics Biotech Inc. (NASDAQ: ONCY) has generated yet another critical validation of its platform, announcing updated clinical data this morning demonstrating the activity of pelareorep in third-line metastatic anal cancer.

Article content

In the high-stakes world of oncology, survival data is the only currency that doesn’t devalue.

Article content

The findings from the GOBLET trial continue to prove that pelareorep is a “Universal Key” for gastrointestinal tumors, successfully turning “cold” cancers into visible targets for the immune system.

Article content

This fresh efficacy signal follows the company’s recent recruitment of the world’s top oncologists from Memorial Sloan Kettering to its advisory board. Experts who follow data, not narratives.